Heron Therapeutics, Inc. (HRTX) vs LeonaBio, Inc. (LONA)
Heron Therapeutics, Inc. and LeonaBio, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and LeonaBio, Inc. are of similar size ($57.0M and $54.3M). LeonaBio, Inc. has the higher net margin (0.00% vs −22.5%) and the higher return on invested capital (0.00% vs −6.35%). Across the 14 metrics below, LeonaBio, Inc. leads on 8 and Heron Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | HRTX | LONA | Biotechnology median |
|---|---|---|---|
| Gross margin | 70.07% | 0.00% | 65.16% |
| Operating margin | (7.19%) | 0.00% | 0.00% |
| Net margin | (22.52%) | 0.00% | 0.00% |
| Free cash flow margin | (8.00%) | 0.00% | 0.00% |
| Return on equity | 318.21% | (431.39%) | (57.72%) |
| Return on assets | (14.06%) | (306.05%) | (49.22%) |
| Return on invested capital | (6.35%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack